Company Filing History:
2 out of 1,713 
1 out of 181 
1 out of 18 Years Active: 2010-2018
Title: The Innovations of Gee-Chen Chang
Introduction
Gee-Chen Chang is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of cancer research, particularly in the development of methods for predicting lung cancer and post-treatment survival in cancer patients. With a total of 3 patents, his work has the potential to impact the lives of many individuals facing cancer diagnoses.
Latest Patents
One of his latest patents is a method or kit for determining lung cancer development. This invention discloses a method for assessing whether a subject is at risk of developing lung cancer by identifying the presence of the SNP locus of rs193100333. This specific mutation on the YAP1 protein indicates a risk for lung cancer. Additionally, he has developed a method for predicting post-treatment survival in cancer patients based on the expression levels of specific microRNAs, including hsa-miR137, hsa-miR372, hsa-miR182*, hsa-miR221, and hsa-let-7a.
Career Highlights
Gee-Chen Chang has worked with prestigious institutions such as National Taiwan University and National Health Research Institutes. His experience in these organizations has allowed him to collaborate with other experts in the field and further his research endeavors.
Collaborations
Some of his notable coworkers include Sung-Liang Yu and Hsuan-Yu Chen. Their collaborative efforts have contributed to the advancements in cancer research and the development of innovative solutions.
Conclusion
Gee-Chen Chang's work exemplifies the importance of innovation in the medical field, particularly in cancer research. His patents and collaborations highlight his commitment to improving patient outcomes and advancing scientific knowledge.